M&A Deal Summary

LabCorp Acquires Sequenom

On July 27, 2016, LabCorp acquired life science company Sequenom for 371M USD

Acquisition Highlights
  • This is LabCorp’s 18th transaction in the Life Science sector.
  • This is LabCorp’s 7th largest (disclosed) transaction.
  • This is LabCorp’s 27th transaction in the United States.
  • This is LabCorp’s 6th transaction in California.

M&A Deal Summary
Date 2016-07-27
Target Sequenom
Sector Life Science
Buyer(s) LabCorp
Deal Type Add-on Acquisition
Deal Value 371M USD
Advisor(s) J.P. Morgan Securities (Financial)
Cooley (Legal)

Target

Sequenom

San Diego, California, United States
Sequenom, Inc. is a provider of genetic analysis products that translate the results of genomic science into solutions for noninvasive prenatal diagnostics, biomedical research, translational research and molecular medicine applications, especially in women’s health.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

LabCorp

Burlington, North Carolina, United States
Category Company
Sector Test/Measurement Equipment
Employees67,000
Revenue 12.2B USD (2023)
DESCRIPTION
LabCorp's corporate headquarters in downtown Burlington, North Carolina.
LabCorp's corporate headquarters in downtown Burlington, North Carolina.

LabCorp of America Holdings is a provider of medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp is based in Burlington, North Carolina.

DEAL STATS #
Overall 29 of 44
Sector (Life Science) 18 of 21
Type (Add-on Acquisition) 22 of 28
State (California) 6 of 8
Country (United States) 27 of 42
Year (2016) 1 of 2
Size (of disclosed) 7 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-10 Pathology

Torrance, California, United States

Pathology, Inc. is a full-service independent women's health laboratory provides expertise in reproductive FDA donor testing as well as anatomic, molecular and digital pathology services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-03 ClearPath Diagnostics

Syracuse, New York, United States

ClearPath Diagnostics is a provider of anatomic pathology practice and laboratory in New York which primarily serves the women's health market. ClearPath provides service to thousands of physicians throughout the Northeastern United States.

Buy -
Mergr

Product

Company

Legal